by GlobeNewsWire | Mar 29, 2016 | Globe Newswire
BASKING RIDGE, N.J., March 29, 2016 (GLOBE NEWSWIRE) — Caladrius Biosciences (NASDAQ:CLBS), (“Caladrius” or the “Company”), a cell therapy company combining an industry-leading development and manufacturing services provider (PCT) with a select therapeutic...
by editor | Feb 11, 2014 | Blog, Breaking News, Medical Stocks
22nd Century Group (OTCQB: XXII) Announced in news today that they believe they meet all of the eligibility requirements for moving to the NYSE MKT. Last week they submitted an initial request to the market for a potential move in the future. A committee with NYSE MKT...
by editor | Jun 8, 2011 | Latest Spotlights
DALLAS, TEXAS : StockGuru announces that 22nd Century Group Inc. (OTCBB: XXII) is in the StockGuru Spotlight. 22nd Century Group, Inc., a biotechnology company, engages in modifying the content of nicotinic alkaloids in plants, including the tobacco plant, through...